Slavica Lazarević, Maja Đanic, Hani Al-Salami, Armin Mooranian, Armin Mooranian, & Momir Mikov. (2022). Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease. Frontiers Media S.A..
Chicago Style (17th ed.) CitationSlavica Lazarević, Maja Đanic, Hani Al-Salami, Armin Mooranian, Armin Mooranian, and Momir Mikov. Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationSlavica Lazarević, et al. Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.